fbpx

Posts

Dr. Daryl Chan

Patients with Recurring Hodgkin Lymphoma Find New Hope in Immunotherapy Cancer Treatment

Press Release At a cancer-treatment forum held recently at the Crowne Plaza in Quezon City, hematologist Dr. Daryl Tan, the Director of Research at the Raffles Hospital in Singapore, narrated a bleak tale: a 25-year-old woman, in the prime of…
Test, Talk, Take Action is a national awareness campaign designed to encourage those impacted by non-small cell lung cancer (NSCLC) to make informed treatment decisions by learning about biomarkers and talking with their health care provider about testing for biomarkers
,

Test, Talk, and Take Action: Battling Lung Cancer

Press Release It is common for Filipinos to dismiss seemingly ordinary health concerns such as body aches, colds or coughs. Seeking the advice of a health professional is often set aside due to time or financial constraints. And despite the…
Dr. Kenneth O’Byrne, Professor of Medical Oncology and Queensland Senior Clinical Research Fellow, presented the results of the Keynote-021 study combining immunotherapy and chemotherapy which showed high response rates that will greatly benefit patients with advanced non-small cell lung cancer

Combination Therapy for lung cancer: a game-changing treatment

Lung cancer is inevitably fatal. The Global Cancer Observatory (GLOBOCAN) Project by the World Health Organization showed that, in 2018, more than 2 million people1 were diagnosed with the disease. Dr. Ted Hamilton of the Florida Hospital Central…
Cancer Heroes

Dear Cancer Heroes: Honoring People in Clinical Trials

“Cancer research” can bring to mind labs, medicines, and graphs showing how well one treatment compares to another. But how often do we think of the people behind those graphs? The patients who participate in clinical trials…
Oncology expert Prof. Byoung-Chul Cho, MD, PhD, describes the results of human research studies supporting the use of pembrolizumab as a more tolerable and more effective mode of treatment for certain cancers than conventional chemotherapy

Immunotherapy Now Approved in PH as Treatment Option for Lung Cancer 

Press Release The landscape of cancer therapy in the country undergoes a dramatic change as the Philippine Food and Drug Administration (FDA) finally approves a non-chemotherapy drug that is already considered as treatment option in many countries…
Professor Morteza Aghmesheh

Immunotherapy Brings New Hope for Advanced Head and Neck Cancer Patients

Press Release For this 78-year-old patient, it seemed like the end of the line. His battle with cancer started two years ago when he was first diagnosed with early stage tonsil cancer. Within six to eight months, the disease had already spread…
Dr. Margaret Louise McGrath, senior staff specialist at the Medical Oncology Division of Cancer Services at Princess Alexandra Hospital, Queensland shared the recent clinical trials on immunotherapy for the treatment of head and neck cancers which showed positive response rates and better hope for recovery for patients during the annual gathering of the Philippine Society of Medical Oncology

Immunotherapy brings Hope for Head and Neck Cancer Patients

Press Release    The World Health Organization’s Globocan Project ranked head and neck cancer (HNC) as the 6th most common cancer worldwide. There are an estimated 650,000 cases across the world, with 200,000 deaths annually. It may…
Test, Talk, Take Action is a national awareness campaign designed to encourage those impacted by non-small cell lung cancer (NSCLC) to make informed treatment decisions by learning about biomarkers and talking with their health care provider about testing for biomarkers

New Biomarker Vital In Immunotherapy for Lung Cancer

Press Release In the Philippines, lung cancer is the second top fatal malignancy in terms of incidence and mortality.  The good news is that recent developments in cancer treatments have spelled a viable alternative to chemotherapy, which brings…
MSD in the Philippines team joins oncology expert Prof. Byoung-Chul Cho, MD, PhD, at the announcement of pembrolizumab as an approved targeted immunotherapy drug for the first-line treatment for non–small-cell lung cancer

Immunotherapy: A Bright Future for Cancer Treatment 

by: Blessie Adlaon In the past decades, the diagnosis of late-stage cancer for a patient invariably meant long periods of chemotherapy—a treatment that is just a little less deadly than the disease itself.  Recently, however, a new mode of…